Health-Related Quality of Life as Measured by the 36-Item Short Form Survey Among Adults With Acute Bacterial Skin and Skin Structure Infections who Received Either Omadacycline or Linezolid in a Phase 3 Double-Blind, Double-Dummy Clinical Trial

This analysis of data from a Phase 3 study of adults with acute bacterial skin and skin structure infections showed that successful oral treatment with omadacycline (n = 368) or linezolid (n = 367) was associated with improvement in health-related quality of life.

Detalles Bibliográficos
Autores principales: Chitra, Surya, Hinahara, Jordan, Goss, Thomas F, Gunter, Kyle, LaPensee, Kenneth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530258/
https://www.ncbi.nlm.nih.gov/pubmed/34692889
http://dx.doi.org/10.1093/ofid/ofab459
_version_ 1784586633633333248
author Chitra, Surya
Hinahara, Jordan
Goss, Thomas F
Gunter, Kyle
LaPensee, Kenneth
author_facet Chitra, Surya
Hinahara, Jordan
Goss, Thomas F
Gunter, Kyle
LaPensee, Kenneth
author_sort Chitra, Surya
collection PubMed
description This analysis of data from a Phase 3 study of adults with acute bacterial skin and skin structure infections showed that successful oral treatment with omadacycline (n = 368) or linezolid (n = 367) was associated with improvement in health-related quality of life.
format Online
Article
Text
id pubmed-8530258
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-85302582021-10-22 Health-Related Quality of Life as Measured by the 36-Item Short Form Survey Among Adults With Acute Bacterial Skin and Skin Structure Infections who Received Either Omadacycline or Linezolid in a Phase 3 Double-Blind, Double-Dummy Clinical Trial Chitra, Surya Hinahara, Jordan Goss, Thomas F Gunter, Kyle LaPensee, Kenneth Open Forum Infect Dis Brief Reports This analysis of data from a Phase 3 study of adults with acute bacterial skin and skin structure infections showed that successful oral treatment with omadacycline (n = 368) or linezolid (n = 367) was associated with improvement in health-related quality of life. Oxford University Press 2021-09-08 /pmc/articles/PMC8530258/ /pubmed/34692889 http://dx.doi.org/10.1093/ofid/ofab459 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Brief Reports
Chitra, Surya
Hinahara, Jordan
Goss, Thomas F
Gunter, Kyle
LaPensee, Kenneth
Health-Related Quality of Life as Measured by the 36-Item Short Form Survey Among Adults With Acute Bacterial Skin and Skin Structure Infections who Received Either Omadacycline or Linezolid in a Phase 3 Double-Blind, Double-Dummy Clinical Trial
title Health-Related Quality of Life as Measured by the 36-Item Short Form Survey Among Adults With Acute Bacterial Skin and Skin Structure Infections who Received Either Omadacycline or Linezolid in a Phase 3 Double-Blind, Double-Dummy Clinical Trial
title_full Health-Related Quality of Life as Measured by the 36-Item Short Form Survey Among Adults With Acute Bacterial Skin and Skin Structure Infections who Received Either Omadacycline or Linezolid in a Phase 3 Double-Blind, Double-Dummy Clinical Trial
title_fullStr Health-Related Quality of Life as Measured by the 36-Item Short Form Survey Among Adults With Acute Bacterial Skin and Skin Structure Infections who Received Either Omadacycline or Linezolid in a Phase 3 Double-Blind, Double-Dummy Clinical Trial
title_full_unstemmed Health-Related Quality of Life as Measured by the 36-Item Short Form Survey Among Adults With Acute Bacterial Skin and Skin Structure Infections who Received Either Omadacycline or Linezolid in a Phase 3 Double-Blind, Double-Dummy Clinical Trial
title_short Health-Related Quality of Life as Measured by the 36-Item Short Form Survey Among Adults With Acute Bacterial Skin and Skin Structure Infections who Received Either Omadacycline or Linezolid in a Phase 3 Double-Blind, Double-Dummy Clinical Trial
title_sort health-related quality of life as measured by the 36-item short form survey among adults with acute bacterial skin and skin structure infections who received either omadacycline or linezolid in a phase 3 double-blind, double-dummy clinical trial
topic Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530258/
https://www.ncbi.nlm.nih.gov/pubmed/34692889
http://dx.doi.org/10.1093/ofid/ofab459
work_keys_str_mv AT chitrasurya healthrelatedqualityoflifeasmeasuredbythe36itemshortformsurveyamongadultswithacutebacterialskinandskinstructureinfectionswhoreceivedeitheromadacyclineorlinezolidinaphase3doubleblinddoubledummyclinicaltrial
AT hinaharajordan healthrelatedqualityoflifeasmeasuredbythe36itemshortformsurveyamongadultswithacutebacterialskinandskinstructureinfectionswhoreceivedeitheromadacyclineorlinezolidinaphase3doubleblinddoubledummyclinicaltrial
AT gossthomasf healthrelatedqualityoflifeasmeasuredbythe36itemshortformsurveyamongadultswithacutebacterialskinandskinstructureinfectionswhoreceivedeitheromadacyclineorlinezolidinaphase3doubleblinddoubledummyclinicaltrial
AT gunterkyle healthrelatedqualityoflifeasmeasuredbythe36itemshortformsurveyamongadultswithacutebacterialskinandskinstructureinfectionswhoreceivedeitheromadacyclineorlinezolidinaphase3doubleblinddoubledummyclinicaltrial
AT lapenseekenneth healthrelatedqualityoflifeasmeasuredbythe36itemshortformsurveyamongadultswithacutebacterialskinandskinstructureinfectionswhoreceivedeitheromadacyclineorlinezolidinaphase3doubleblinddoubledummyclinicaltrial

Ejemplares similares